Related references
Note: Only part of the references are listed.Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer
Gillian Thomas et al.
GYNECOLOGIC ONCOLOGY (2008)
Darbepoetin alfa for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study
Robert E. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology American Society of Clinical Oncology clinical practice guideline update
J. Douglas Rizzo et al.
BLOOD (2008)
Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: A randomized trial of the radiation therapy oncology group (RTOG 99-03)
Mitchell Machtay et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Do erythropoietin receptors on cancer cells explain unexpected clinical findings?
Bernardino Clavo
JOURNAL OF CLINICAL ONCOLOGY (2007)
Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia
James R. Wright et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Preclinical studies of erythropoietin receptor expression in tumour cells:: Impact on clinical use of erythropoietic proteins to correct cancer-related anaemia
Anders Osterborg et al.
EUROPEAN JOURNAL OF CANCER (2007)
Do erythropoietin receptors on cancer cells explain unexpected clinical findings?
Michael Henke et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Erythropoietin administration during primary treatment for locally advanced cervical carcinoma is associated with poor response to radiation
S. M. Temkin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Recombinant human erythropoietins and cancer patients: Updated meta-analysis of 57 studies including 9353 patients
Julia Bohlius et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Cancer-related anemia and recombinant human erythropoietin - an updated overview
J Bohlius et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study
B Leyland-Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Anemia, tumor hypoxemia, and the cancer patient
J Varlotto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:: randomised, double-blind, placebo-controlled trial
M Henke et al.
LANCET (2003)
Breast cancer trial with erythropoietin terminated unexpectedly
B Leyland-Jones
LANCET ONCOLOGY (2003)
Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies:: a randomized, double-blind, placebo-controlled study
M Hedenus et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Share Paper
